- Who can participate: Adults aged 18 to 65 years with a diagnosis of hypertension may be eligible to participate. Key eligibility criteria include stable medication regimen and no history of cardiovascular events in the past year.
- Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo. They will be required to attend regular clinic visits for blood pressure monitoring and assessment of any side effects.
How understandable was the trial content above?
Hard to understand
Easy to understand
